Value-Based Business Models: A Transformation in the Making for Pharma?
By

By
A recent study by the investment firm, Lazard Partners, of more than 200 healthcare executives and 80 healthcare investors, underscores the development of value-based care business models as a transformation…

Risk Management Maturity: Where Does the Pharma Industry Rank?
By

By
A recent analysis by PwC of 1,500 executives across 30 industries shows that the most successful companies make risk management a more collaborative, measurable, and strategic function among the board,…

Blockchain Technology: A Tool for Procurement or Not?
By

By
Blockchain technology has all the buzz in the banking and financial services industries, but does it have potential for procurement and managing the supply chain? Blockchain technologies use software, communications,…

What Makes a High-Performing Procurement Team?
By

By
A recent study by A.T. Kearney provides benchmarks for a proprietary metric, return on supply management assets, and characterizes the attributes, achievements, and leadership agendas of top-performing procurement organizations. So…

Big Data and Pharma: Where Is the Greatest Impact?
By

By
Data and the analysis of that data guide drug development, product decisions, dosing and patient use, and pricing and reimbursement policy. Big Data may be where it is at, but…

What Does it Take To Be a World-Class Procurement Organization?
By

By
A recent benchmarking analysis by The Hackett Group outlines the performance advantages of world-class procurement organizations. So what did the study find? . The study outlines five key imperatives needed…

Sustainability: What Is on the Minds of CEOs?
By

By
The International Chamber of Commerce and the UN Global Compact recently formed a partnership to improve awareness, opportunities, and participation of the private sector in support of the UN 2030…

Risk Management: Is Your Company Properly Aligned?
By

By
Is your company properly aligned to manage risk? A recent analysis by PwC provides insight on the key characteristics used by high-performing companies to demonstrate strategic risk alignment. The study…

Moving Beyond Traditional Paradigms in Sourcing and Procurement
By

By
How can pharmaceutical companies and suppliers move beyond traditional paradigms in sourcing and procurement and advance more strategic partnerships to meet desired business goals? Leading industry experts share perspectives. More…

Executive Insights: 12 Macro Trends Impacting Supply Risk
By

By
A recent study by A.T. Kearney identifies 12 macro trends that will play a major role in the current and future operating environment for businesses and in particular for global…